Augmedix stock falls 41% after it lowers FY24 revenue guidance
San Francisco-based AI-enabled ambient automation platform Augmedix saw its stock price drop more than 40% after reporting it observed a slowdown in provider purchasing commitments and downgrading its 2024 full-year revenue outlook from $60…
Continue Reading